Skip to main content

EDITORIAL article

Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1542233
This article is part of the Research Topic Fighting Antimicrobial Resistance in Developing Countries: Innovative Approaches and Challenges View all 9 articles

Editorial: Fighting Antimicrobial Resistance in Developing Countries: Innovative Approaches and Challenges

Provisionally accepted
  • 1 Istanbul Technical University, Istanbul, Türkiye
  • 2 University of Stavanger, Stavanger, Norway
  • 3 Dongguk University Seoul, Seoul, Seoul, Republic of Korea
  • 4 UK Centre for Ecology and Hydrology (UKCEH), Wallingford, Oxfordshire, United Kingdom

The final, formatted version of the article will be published soon.

    Antimicrobial resistance (AMR) has emerged as a global health concern, particularly influencing developing countries. Limited healthcare infrastructure, socio-economic disparities, and cultural practices complicates efforts to combat AMR in these regions. Fighting Antimicrobial Resistance in Developing Countries: Innovative Approaches and Challenges features eight collection of studies giving critical insights into the molecular epidemiology, environmental factors, and public health issues of AMR and highlights the urgent need for integrated, multidisciplinary strategies. In developing countries, the necessity of robust surveillance systems to monitor AMR trends and resistance mechanisms were highlighted by several contributors. Wei et al. (2003) provided a detailed analysis of Helicobacter pylori resistance patterns in Nanjing, China and revealed significant multidrug resistance rates, especially against metronidazole and levofloxacin. As a conclusion, they suggested implementation of genotypic resistance testing to enhance related treatment efficacy. Similarly, Li et al. (2004) presented molecular epidemiological data on Klebsiella pneumoniae in China, identifying carbapenem-resistant strains harboring blaKPC-2 and blaNDM genes. These studies emphasized the critical role of molecular surveillance in developing targeted and effective strategies against AMR across clinical and public health domains. The transmission of AMR through animals and the environment is another theme explored in this collection. Tartor et al. (2024) reported the presence of pan drug-resistant carbapenemase-producing Enterobacterales in dogs and cats in Egypt. In their work, the potential for cross-species transmission of AMR was highlighted and the urgent need for enhanced management of antibiotic usage in veterinary practices were suggested. Baleivanualala et al. (2024) studied the extend of environmental contamination in Fijian hospitals by examining carbapenem-resistant Acinetobacter baumannii on high-touched surfaces. In their study, phylogenetic links between environmental and clinical isolates were identified. Their work demonstrated the persistence of carbapenem-resistant pathogens on hospital surfaces and the critical role of patients, healthcare workers, and the hospital environment in the transmission of AMR pathogens. Their results pointed out that rigorous infection control measures are needed to prevent hospital-acquired infections. AMR among vulnerable members of populations is further examined by Khafaja et al. (2004). Multidrug-resistant Gram-negative bacterial infections were examined in immunocompromised pediatric patients in Lebanon. Their study identified chemotherapy and thrombocytopenia as significant risk factors. The need for improvement of antimicrobial stewardship programs and regular updates to treatment guidelines for these high-risk groups were emphasized. Liu et al. (2004) provided insights into the resistance and virulence profiles of Streptococcus agalactiae in dairy farms in northern China. A strong correlation between tetracycline resistance phenotypes and genotypes was demonstrated while the importance of monitoring zoonotic AMR to protect both animal and human health was underlined. In this collection molecular mechanisms driving AMR were further investigated by several authors. Mendes et al. (2024) presented a systematic review linking specific gene mutations in Neisseria gonorrhoeae to resistance against key antibiotics. Their work contributed to understanding of resistance mechanisms, particularly the roles of penA and gyrA mutations. Lau et al. (2024) highlighted the silent spread of extended-spectrum β-lactamase (ESBL) genotypes in phenotypically susceptible Escherichia coli and Klebsiella pneumoniae isolates in Malaysia. Their findings raised concerns about the underestimation of AMR in clinical settings. and the inclusion of genotypic testing in routine diagnostics were suggested. Collectively, the studies in the research topic highlight the urgent need for improved infection control protocols and molecular epidemiological analyses to track and mitigate AMR in healthcare settings. These studies emphasize the importance of surveillance, molecular diagnostics, environmental interventions, and community-based strategies to effectively address the AMR issues in developing countries.

    Keywords: Antimicrobial resistance (AMR), Developing Countries, multidrug resistance, 14 environmental contamination, One Health 15

    Received: 09 Dec 2024; Accepted: 18 Dec 2024.

    Copyright: © 2024 Katipoglu-Yazan, Pala-Ozkok, Cho and Uluseker. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Cansu Uluseker, UK Centre for Ecology and Hydrology (UKCEH), Wallingford, OX10 8BB, Oxfordshire, United Kingdom

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.